Pharming Group N.V. (PHAR) announced, for the full year 2023, total revenues are expected to increase by 19% to approximately $245 million. For 2023, the company expects RUCONEST revenues to increase by 10% to approximately $227 million. For the full year 2023, the company expects Joenja revenues of approximately $18 million.
from RTT - Earnings https://ift.tt/UrkleVi
via IFTTT
No comments:
Post a Comment